OTC · CBIH
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 5:54 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CBIH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning CBIH.
CBIH research
Company profile and research snapshot.
CANNABIS BIOSCI INTL HLDG
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Jul 15, 2024
Cannabis Bioscience International Holdings (CBIH) has filed applications for crucial licenses to expand its manufacturing, production, and retail operations in the cannabis market. The company is focused on developing cannabis-based products as dietary supplements and nutraceuticals, adhering to federal and state regulations.
GlobeNewswire Inc. · Jun 26, 2024
As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's distributor
GlobeNewswire Inc. · Jun 17, 2024
CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.
GlobeNewswire Inc. · Jun 5, 2024
“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CBIH.
